Lora Zhao

2.1k total citations
7 papers, 340 citations indexed

About

Lora Zhao is a scholar working on Cancer Research, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Lora Zhao has authored 7 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cancer Research, 2 papers in Molecular Biology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Lora Zhao's work include CAR-T cell therapy research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Lora Zhao is often cited by papers focused on CAR-T cell therapy research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Lora Zhao collaborates with scholars based in United States, Switzerland and Germany. Lora Zhao's co-authors include Steven J. Pitts, Dilduz Telman, Purnima Sundar, Tracy C. Kuo, Shengzhi Wang, Mia Derstine, Stephen L. Hauser, H.‐Christian von Büdingen, Leonard Apeltsin and Marina Sirota and has published in prestigious journals such as Journal of Molecular Biology, Science Translational Medicine and Molecular Cancer Therapeutics.

In The Last Decade

Lora Zhao

6 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lora Zhao United States 5 138 120 114 79 76 7 340
Rocío Ramos‐Medina Spain 12 113 0.8× 79 0.7× 63 0.6× 110 1.4× 14 0.2× 21 341
Felix Marsh‐Wakefield Australia 11 165 1.2× 56 0.5× 89 0.8× 80 1.0× 25 0.3× 29 343
Qunmin Zhou United States 7 251 1.8× 62 0.5× 84 0.7× 93 1.2× 23 0.3× 8 381
Cristina López Spain 9 211 1.5× 220 1.8× 77 0.7× 113 1.4× 15 0.2× 11 415
René Scholtysik Germany 13 116 0.8× 193 1.6× 153 1.3× 136 1.7× 12 0.2× 25 448
H Yuasa Japan 8 212 1.5× 75 0.6× 127 1.1× 64 0.8× 127 1.7× 12 377
Ann‐Katrin Clauder Germany 6 155 1.1× 31 0.3× 72 0.6× 58 0.7× 47 0.6× 7 320
Valérie Hanssens Belgium 5 78 0.6× 49 0.4× 91 0.8× 23 0.3× 100 1.3× 8 358
Hai Hong China 11 181 1.3× 27 0.2× 88 0.8× 125 1.6× 15 0.2× 15 304
W Knapp Austria 11 205 1.5× 54 0.5× 126 1.1× 53 0.7× 68 0.9× 21 407

Countries citing papers authored by Lora Zhao

Since Specialization
Citations

This map shows the geographic impact of Lora Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lora Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lora Zhao more than expected).

Fields of papers citing papers by Lora Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lora Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lora Zhao. The network helps show where Lora Zhao may publish in the future.

Co-authorship network of co-authors of Lora Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Lora Zhao. A scholar is included among the top collaborators of Lora Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lora Zhao. Lora Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
2.
Harris, Benjamin, Yogin Patel, Lora Zhao, et al.. (2022). 340 The Epi-RTM technology produces a polyclonal TIL product (LYL845) with diverse tumor-reactive clones that have stem-like qualities and anti-tumor function. Regular and Young Investigator Award Abstracts. A358–A358. 3 indexed citations
3.
Blarcom, Thomas Van, Andrea Rossi, Davide Foletti, et al.. (2018). Epitope Mapping Using Yeast Display and Next Generation Sequencing. Methods in molecular biology. 1785. 89–118. 8 indexed citations
4.
Blarcom, Thomas Van, Andrea Rossi, Davide Foletti, et al.. (2014). Precise and Efficient Antibody Epitope Determination through Library Design, Yeast Display and Next-Generation Sequencing. Journal of Molecular Biology. 427(6). 1513–1534. 50 indexed citations
5.
Palanichamy, Arumugam, Leonard Apeltsin, Tracy C. Kuo, et al.. (2014). Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis. Science Translational Medicine. 6(248). 248ra106–248ra106. 173 indexed citations
6.
Bentzien, Frauke, Yongchang Shi, Peiwen Yu, et al.. (2013). In Vitro and In Vivo Activity of Cabozantinib (XL184), an Inhibitor of RET, MET, and VEGFR2, in a Model of Medullary Thyroid Cancer. Thyroid. 23(12). 1569–1577. 102 indexed citations
7.
Müller, Thomas, Samuel E. DePrimo, Peiwen Yu, et al.. (2009). Abstract B269: Pharmacodynamic and correlative biomarker analyses in clinical trials of XL184, an oral, potent inhibitor of MET, VEGFR2, and RET. Molecular Cancer Therapeutics. 8(12_Supplement). B269–B269. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026